Zevra Therapeutics, Inc. ZVRA Enterprise value

Enterprise value at other companies

BioMarin PharmaceuticalsBMRN

$14.37B+45.5%

Ultragenyx PharmaceuticalRARE

$1.83B-51.1%

RFL

Rafael Holdings, Inc.RFL

$52.06M+46.1%

Rigel PharmaceuticalsRIGL

$543.41M+96.3%

XER

Xeris Biopharma Holdings, Inc.XERS

$1.54B+62.6%

Theravance BiopharmaTBPH

$588.13M+55.1%

FAQ

What is Zevra Therapeutics, Inc.'s enterprise value?

Zevra Therapeutics, Inc. (ZVRA) reported enterprise value of $703.89M in Q2 2026.

How has Zevra Therapeutics, Inc.'s enterprise value changed year-over-year?

Zevra Therapeutics, Inc.'s enterprise value increased by 36.7% year-over-year, from $514.88M to $703.89M.

What is the long-term trend for Zevra Therapeutics, Inc.'s enterprise value?

Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s enterprise value has grown at a 60.5% compound annual growth rate (CAGR), from $47.46M to $505.23M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.